The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer

PURPOSE: The CRP/albumin (Alb) ratio, a recently reported predictor, has shown value for prognosis in various human cancers. This study aimed to determine the prognostic value of baseline CRP/Alb and to explore the relevance between postchemotherapy CRP/Alb and the efficacy of chemotherapy in advanc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Fan, Zhiyao, Fan, Kun, Gong, Yitao, Huang, Qiuyi, Yang, Chao, Cheng, He, Jin, Kaizhou, Ni, Quanxing, Yu, Xianjun, Luo, Guopei, Liu, Chen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778322/
https://ncbi.nlm.nih.gov/pubmed/31632137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S211363
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak